Tag Archives: TROX

Hot Low Price Stocks To Own For 2019

They say that big things come in small packages, and sometimes the same can be said about stock prices. There are plenty of stocks trading in the single digits, and while most of them — let’s face it — are there for a reason, risk-tolerant investors can sometimes find some real gems among low-priced equities. 

Sirius XM Holdings (NASDAQ:SIRI), Glu Mobile (NASDAQ:GLUU), Fitbit (NYSE:FIT), GoPro (NASDAQ:GPRO), Zynga (NASDAQ:ZNGA), Rite Aid (NYSE:RAD), and Groupon (NASDAQ:GRPN) are some of the big names with low prices that I’m watching these days. Let’s take a closer look at these seven stocks trading for $7 or less. 

Image source: Sirius XM Holdings.

1. Sirius XM Holdings — $6.94

Not every stock trading in the single digits is a loser. Sirius XM stock has been a nearly 140-bagger since bottoming out at a nickel in 2009. The satellite radio provider has been a beast over the years. The shares are trading higher for the 10th year in a row. 

Hot Low Price Stocks To Own For 2019: SandRidge Permian Trust(PER)

Advisors’ Opinion:

  • [By Max Byerly]

    Media coverage about SandRidge Permian Trust (NYSE:PER) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. SandRidge Permian Trust earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave news headlines about the oil and gas producer an impact score of 46.3601951962152 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Hot Low Price Stocks To Own For 2019: Vince Holding Corp.(VNCE)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Jeremy Bowman]

    However, the economy is still thriving, and a number of apparel stocks have surged in recent months as the worst of the “retail apocalypse” appears to have passed. Retail stocks may not be the first place investors look for big returns, but all three of these stocks have tripled over the past year. Let’s see why Vince Holding (NYSE:VNCE), Canada Goose (NYSE:GOOS), and Fossil Group (NASDAQ:FOSL)have all soared.

  • [By Shane Hupp]

    Francesca’s (NASDAQ: FRAN) and Vince (NYSE:VNCE) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Hot Low Price Stocks To Own For 2019: iShares 20+ Year Treasury Bond (TLT)

Advisors’ Opinion:

  • [By Logan Wallace]

    TRADEMARK VIOLATION WARNING: “Theralase Technologies (TLT) Hits New 52-Week High at $0.50” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/4158304/theralase-technologies-tlt-hits-new-52-week-high-at-0-50.html.

  • [By Shane Hupp]

    iShares Barclays 20+ Yr Treas.Bond (NASDAQ:TLT) announced a monthly dividend on Monday, July 2nd, Wall Street Journal reports. Stockholders of record on Tuesday, July 3rd will be given a dividend of 0.2749 per share by the exchange traded fund on Monday, July 9th. This represents a $3.30 annualized dividend and a dividend yield of 2.72%. The ex-dividend date of this dividend is Monday, July 2nd.

  • [By Luke Kawa]

    All of these low-duration ETFs are trouncing their peers that carry a high degree of interest rate risk — like Vanguard’s Long-Term Bond ETF (BLV) and the iShares 20+ Year Treasury Bond ETF (TLT) — out of the gate in 2018.

  • [By Shane Hupp]

    News stories about iShares Barclays 20+ Yr Treas.Bond (NASDAQ:TLT) have been trending positive recently, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. iShares Barclays 20+ Yr Treas.Bond earned a news sentiment score of 0.30 on Accern’s scale. Accern also gave news stories about the exchange traded fund an impact score of 46.3455679399619 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Hot Low Price Stocks To Own For 2019: Tronox Limited(TROX)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    One factor contributing to the awful start to life as a publicly traded company is simply timing. Venator Materials stock listed on public exchanges just in time to catch the last few months of a multiyear bonanza for titanium dioxide stocks. Shares of Kronos Worldwide, Chemours, and Tronox Ltd (NYSE:TROX) all jumped by triple digits in the three-year period ending in 2017. That helped to soften the blow from their double-digit declines suffered so far in 2018, but the newcomer has no such history to hang its hat on.

  • [By Joseph Griffin]

    Wolverine Asset Management LLC acquired a new stake in Tronox Ltd (OTCMKTS:TROX) in the second quarter, HoldingsChannel.com reports. The firm acquired 27,200 shares of the basic materials company’s stock, valued at approximately $535,000.

  • [By Maxx Chatsko]

    Shares of Tronox (NYSE:TROX) jumped over 20% today after the company announced it had filed a joint motion with the U.S. Federal Trade Commission to delay the appeal schedule regarding the review of its proposed acquisition of Cristal. The move suggests the titanium dioxide manufacturer and the FTC are making progress toward a compromise over the acquisition of the Saudi-based chemicals producer, which has been under intense regulatory scrutiny for two years. 

  • [By Shane Hupp]

    Tronox (OTCMKTS:TROX) had its target price lowered by equities research analysts at BMO Capital Markets to $13.00 in a report released on Tuesday, The Fly reports. The firm currently has an “outperform” rating on the basic materials company’s stock. BMO Capital Markets’ target price indicates a potential upside of 0.93% from the company’s previous close.

  • [By Stephan Byrd]

    Hydrogenics (NASDAQ: HYGS) and Tronox (NYSE:TROX) are both oils/energy companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Hot Low Price Stocks To Own For 2019: Tutor Perini Corporation(TPC)

Advisors’ Opinion:

  • [By Logan Wallace]

    JPMorgan Chase & Co. reduced its stake in shares of Tutor Perini Corp (NYSE:TPC) by 7.2% during the 1st quarter, Holdings Channel reports. The firm owned 258,952 shares of the construction company’s stock after selling 20,145 shares during the quarter. JPMorgan Chase & Co.’s holdings in Tutor Perini were worth $5,710,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Tutor Perini (TPC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Tutor Perini (TPC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of Tutor Perini Corp (NYSE:TPC) have been assigned an average rating of “Buy” from the ten brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $31.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Tutor Perini (TPC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Tutor Perini (NYSE:TPC) had its price target cut by B. Riley from $28.00 to $26.00 in a research note released on Wednesday. They currently have a buy rating on the construction company’s stock.

Top 10 Medical Stocks To Buy For 2019

source: newcannabisventures

Even though 2017 was an extraordinary year for the growth and momentum of the cannabis industry, 2018 promises to be even better, as acceptance of pot grows – both medically and recreational.

With California making the use of recreational pot legal, and Canada moving toward doing the same across the entire country, it will keep the impetus behind the trend in play.

This is good news for many companies in the indusry, including Aurora Cannabis (OTCQX:ACBFF), which will complete its Aurora Sky project around the time marijuana is legalized in Canada.

Top 10 Medical Stocks To Buy For 2019: Six Flags Entertainment Corporation New(SIX)

Advisors’ Opinion:

  • [By Rick Munarriz]

    The country’s two largest theme park operators have already checked in with their holiday-quarter results, and now it’s time to see how the leading regional amusement park players are doing. Cedar Fair (NYSE:FUN) reports its latest financials on Wednesday morning. Six Flags Entertainment (NYSE:SIX) follows with its earnings release the next morning.

  • [By Shane Hupp]

    Integrity Gaming (OTCMKTS: IGAMF) and Six Flags (NYSE:SIX) are both consumer discretionary companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership.

  • [By Daniel B. Kline]

    In this episode of Industry Focus: Consumer Goods, Vincent Shen and Motley Fool contributor Dan Kline take a first pass at understanding what it takes to run a theme park with three of the biggest names in the industry — Six Flags (NYSE:SIX), Cedar Fair (NYSE:FUN), and SeaWorld (NYSE:SEAS).

  • [By Max Byerly]

    SIX (CURRENCY:SIX) traded down 0.6% against the US dollar during the one day period ending at 15:00 PM Eastern on February 4th. One SIX token can currently be bought for about $0.0061 or 0.00000177 BTC on cryptocurrency exchanges including Coinsuper, Liquid and Stellarport. SIX has a total market cap of $1.68 million and $58,579.00 worth of SIX was traded on exchanges in the last 24 hours. During the last week, SIX has traded down 6.5% against the US dollar.

  • [By Lisa Levin]

    Six Flags Entertainment Corporation (NYSE: SIX) shares were also up, gaining 9 percent to $64.54 as the company posted a narrower-than-expected loss for its first quarter.

Top 10 Medical Stocks To Buy For 2019: Smart(SFS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine lowered shares of Smart & Final Stores (NYSE:SFS) from a sell rating to a strong sell rating in a research report released on Wednesday.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Smart & Final Stores (SFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Smart & Final Stores (SFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Shane Hupp]

    Smart & Final (NYSE: SFS) and Kroger (NYSE:KR) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

  • [By Brian Stoffel]

    But over the past five years, the industry has been turned upside down by changes in business models, a focus on delivery, and mass consolidation. While the dust is far from settled, here are 10 of the largest publicly traded grocers you can buy stock in.

    Company Market Cap Stores Regions Chains
    Amazon (NASDAQ:AMZN) $780 billion 500 USA Whole Foods
    Walmart (NYSE:WMT) $250 billion 11,700 Worldwide Walmart
    Costco (NASDAQ:COST) $86 billion 750 USA Costco
    Kroger (NYSE:KR) $21 billion 2,800 USA Kroger, Roundy’s, Ralph’s, Food 4 Less
    Sprouts (NASDAQ: SFM) $3 billion 300 Western and Southern U.S. Sprouts Farmer’s Market
    Weis Market (NYSE: WMK) $1.3 billion 200 Mid-Atlantic U.S. Weis Market
    SUPERVALU (NYSE: SVU) $630 million 100 Midwestern U.S. Cub Foods, Shopper’s Food, Hornbacher
    Ingles Market (NASDAQ: IMKTA) $580 million 200 Southeastern U.S. Ingles Market, Sav-Mor
    Smart & Final (NYSE: SFS) $360 million 350 Western U.S. Smart & Final, Cash & Carry
    Natural Grocers (NYSE: NGVC) $230 million 150 Western U.S. Natural Grocers

    Data source: Yahoo! Finance, company websites.

Top 10 Medical Stocks To Buy For 2019: Tronox Limited(TROX)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Tronox Ltd (OTCMKTS:TROX) traded down 8.6% on Tuesday . The company traded as low as $10.95 and last traded at $11.09. 1,237,777 shares changed hands during trading, a decline of 7% from the average session volume of 1,334,449 shares. The stock had previously closed at $12.14.

  • [By Maxx Chatsko]

    Shares of Tronox (NYSE:TROX) jumped over 20% today after the company announced it had filed a joint motion with the U.S. Federal Trade Commission to delay the appeal schedule regarding the review of its proposed acquisition of Cristal. The move suggests the titanium dioxide manufacturer and the FTC are making progress toward a compromise over the acquisition of the Saudi-based chemicals producer, which has been under intense regulatory scrutiny for two years. 

  • [By Shane Hupp]

    Tronox (OTCMKTS:TROX) had its target price lowered by equities research analysts at BMO Capital Markets to $13.00 in a report released on Tuesday, The Fly reports. The firm currently has an “outperform” rating on the basic materials company’s stock. BMO Capital Markets’ target price indicates a potential upside of 0.93% from the company’s previous close.

Top 10 Medical Stocks To Buy For 2019: City Holding Company(CHCO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on City (CHCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on City (CHCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy For 2019: Griffin Industrial Realty, Inc.(GRIF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Gazit Globe (NASDAQ: GRIF) and Griffin Industrial Realty (NASDAQ:GRIF) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

  • [By Shane Hupp]

    Wells Fargo & Company MN increased its position in Griffin Land & Nurseries, Inc. (NASDAQ:GRIF) by 155.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,876 shares of the financial services provider’s stock after purchasing an additional 2,358 shares during the quarter. Wells Fargo & Company MN owned approximately 0.08% of Griffin Land & Nurseries worth $142,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Griffin Industrial Realty (NASDAQ:GRIF) and NEW WORLD Dev L/ADR (OTCMKTS:NDVLY) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation.

  • [By Joseph Griffin]

    News headlines about Griffin Industrial Realty (NASDAQ:GRIF) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Griffin Industrial Realty earned a news sentiment score of 0.20 on Accern’s scale. Accern also assigned media headlines about the financial services provider an impact score of 44.889795908597 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 10 Medical Stocks To Buy For 2019: United States Steel Corporation(X)

Advisors’ Opinion:

  • [By Peter Graham]

    “One seemingly interesting bright spot though now that the sector has come off a bit is steel. Two steel stocks in United States Steel Corporation (X) and Steel Dynamics, Inc. (STLD) not only are looking technically attractive once again, they’re offering some nice value on a fundamental basis, albeit for very different reasons.

  • [By Reuben Gregg Brewer]

    However, it also speaks to the flexibility of the company’s growth goals and how they have shifted with the market. When the industry was struggling, Nucor was more willing to expand via acquisition, taking advantage of the downturn to pick up assets at bargain prices. At this point, the overall steel industry is starting to recover, with even financially weak competitors like United States Steel Corporation (NYSE:X) and AK Steel (NYSE:AKS) reporting notably improved financial results in 2017. Now Nucor is shifting gears and working to fine-tune the profile of its business from within.   

  • [By Garrett Baldwin]

    We’re moving deeper and deeper into earnings season. If you’re looking to make real money, the time to get started is now. Money Morning Quantitative Specialist Chris Johnson argues the markets are at a tipping point. And with just a few smart plays in today’s classic stock picker’s market… you can pull in triple-digit gains with just a small investment. Read those picks right here.

    The Top Stock Market Stories for Wednesday
    The Trump administration is considering a 25% tariff on up to $200 billion in Chinese goods. This is the latest escalation of an ongoing trade spat that has ripped through the heartland of the United States and threatens to bring the market rally to a screeching halt. On Tuesday, soybean prices rallied more than $0.28 in Chicago on speculation that the Trump administration is looking to resolve trade relations with China. Following the White House’s announcement, soybeans gave back a majority of those gains as trade fears rattled the agriculture industry. Finally, Apple Inc. (Nasdaq: AAPL) is on the verge of becoming the first $1 trillion company by market capitalization. The firm was close to topping $200 per share on Wednesday morning after a terrific earnings report after the bell yesterday.
    Three Stocks to Watch Today: TSLA, X, CPB
    Will today be the reckoning for Elon Musk’s Tesla Inc. (Nasdaq: TSLA)? Today, the company will report earnings for the second quarter of 2018. The notorious cash-burning company is expected to report a quarterly profit loss of -$2.76 per share on top of $3.79 billion in revenue. The earnings report that is sliding under the radar today is from United States Steel Corp. (NYSE: X). Following the implementation of U.S. President Donald Trump’s steel tariffs on foreign suppliers, it will be interesting to see how the company has fared under the White House’s protectionist policies. In addition, we will want to know if the firm plans to increase its domestic investments and bolster its hiring. Pay a

  • [By Logan Wallace]

    TMX Group Ltd (TSE:X) – Equities researchers at National Bank Financial lowered their Q3 2018 earnings per share estimates for shares of TMX Group in a research report issued on Monday, July 16th. National Bank Financial analyst J. Gloyn now forecasts that the company will post earnings of $1.30 per share for the quarter, down from their prior estimate of $1.33. National Bank Financial currently has a “Outperform” rating and a $88.00 price target on the stock. National Bank Financial also issued estimates for TMX Group’s Q4 2018 earnings at $1.35 EPS and FY2019 earnings at $5.68 EPS.

Top 10 Medical Stocks To Buy For 2019: United Bankshares Inc.(UBSI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    United Bankshares, Inc. (NASDAQ:UBSI) – Analysts at Boenning Scattergood reduced their Q2 2019 earnings estimates for shares of United Bankshares in a research report issued to clients and investors on Wednesday, January 30th. Boenning Scattergood analyst M. Schultheis now anticipates that the financial services provider will post earnings of $0.63 per share for the quarter, down from their previous estimate of $0.64. Boenning Scattergood has a “Hold” rating on the stock. Boenning Scattergood also issued estimates for United Bankshares’ Q3 2019 earnings at $0.65 EPS, Q4 2019 earnings at $0.63 EPS, FY2019 earnings at $2.55 EPS and FY2020 earnings at $2.60 EPS.

  • [By ]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , American Airlines (AAL) , Align Technology (ALGN) , Procter & Gamble (PG) , United Bankshares (UBSI) , Valeant Pharmaceuticals (VRX) and Dominion Energy (D) .

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on United Bankshares (UBSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    BidaskClub upgraded shares of United Bankshares (NASDAQ:UBSI) from a hold rating to a buy rating in a research report sent to investors on Saturday.

  • [By Shane Hupp]

    Shares of United Bankshares, Inc. (NASDAQ:UBSI) have been assigned an average recommendation of “Hold” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $39.33.

Top 10 Medical Stocks To Buy For 2019: Encore Wire Corporation(WIRE)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub cut shares of Encore Wire (NASDAQ:WIRE) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

    A number of other research analysts also recently commented on the company. Zacks Investment Research raised Encore Wire from a sell rating to a hold rating in a report on Friday, August 10th. DA Davidson set a $60.00 target price on Encore Wire and gave the stock a buy rating in a report on Thursday, August 2nd. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. Encore Wire presently has a consensus rating of Hold and a consensus price target of $60.00.

  • [By Logan Wallace]

    Encore Wire (NASDAQ: WIRE) and Arconic (NYSE:ARNC) are both industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Top 10 Medical Stocks To Buy For 2019: Cal-Maine Foods, Inc.(CALM)

Advisors’ Opinion:

  • [By Logan Wallace]

    Cal-Maine Foods Inc (NASDAQ:CALM) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $52.15 and last traded at $52.25, with a volume of 5956 shares trading hands. The stock had previously closed at $51.05.

  • [By Joseph Griffin]

    Cal-Maine Foods Inc (NASDAQ:CALM) has earned an average recommendation of “Hold” from the six brokerages that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $55.00.

  • [By Garrett Baldwin]

    Get an exclusive invitation to meet Tim before everyone else right here.

    Three Stocks to Watch Today: LC, GE, GS
    General Electric Co. (NYSE: GE) has ousted its CEO John Flannery. Shares are up more than 10% as investors celebrated the news. GE has been mired in a slump, particularly its turbine business. The firm’s new CEO is H. Lawrence Culp, Jr., the former CEO of the industrial firm Danaher. Shares of LendingClub Corp. (NYSE: LC) are under pressure after the SEC charged one of the firm’s divisions with mishandling client money. This weekend, the firm reached a settlement with regulators on charges that the firm inflated its revenue and made changes to products to make the firm look healthier than it is. As a result, the firm’s board of directors forced CEO Renaud Laplanche to resign. Goldman Sachs Group Inc. (NYSE: GS) has replaced CEO Lloyd Blankfein, who has stepped down after more than a decade at the helm at one of Wall Street’s most iconic banks. David Solomon – who has previously served as the firm’s president and COO – will now bet the new CEO. His tenure begins at a tough time for Goldman as the bank struggles with lower trading desk revenues. Look for earnings reports today from Cal-Maine Foods Inc. (NASDAQ: CALM) and Xcerra Corp. (NASDAQ: XCRA).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Shane Hupp]

    News headlines about Cal-Maine Foods (NASDAQ:CALM) have trended somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cal-Maine Foods earned a news sentiment score of 0.21 on Accern’s scale. Accern also assigned media stories about the basic materials company an impact score of 45.5279430715424 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Dan Caplinger]

    Monday was generally a good day for the stock market, although major benchmarks showed a considerable amount of variation in how they performed. The Dow Jones Industrial Average and S&P 500 seemed to benefit the most from news that the U.S., Mexico, and Canada had resolved their trade differences and come to a trilateral agreement, but the Nasdaq Composite lagged, and small-cap stocks posted substantial declines. Also hurting the overall market were some disturbing developments regarding some key companies. Infinera (NASDAQ:INFN), Akorn (NASDAQ:AKRX), and Cal-Maine Foods (NASDAQ:CALM) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Medical Stocks To Buy For 2019: Owens Corning Inc(OC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Owens Corning (NYSE:OC) was the target of some unusual options trading activity on Monday. Stock investors acquired 28,306 call options on the stock. This is an increase of approximately 4,772% compared to the average volume of 581 call options.

  • [By Maxx Chatsko]

    Shares of Owens Corning (NYSE:OC) dropped as much as 14% today after the company announced second-quarter 2018 earnings. The manufacturer of roofing materials, building insulation, and composites delivered a relatively solid performance compared to the year-ago period, with revenue up 14% and net income up 26%.

  • [By Ethan Ryder]

    Owens Corning (NYSE:OC) has been given an average rating of “Hold” by the twenty-one brokerages that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $82.13.

  • [By Neha Chamaria, Chris Neiger, and Maxx Chatsko]

    Three of our Motley contributors have identified a trio of such value stocks you could consider buying right now: Owens Corning (NYSE:OC), Brookfield Infrastructure Partners (NYSE:BIP), and General Motors (NYSE:GM). Here’s what makes these stocks so compelling.

Top 5 Value Stocks To Buy For 2018

Retirees can draw a crucial investment lesson from studying the two major anniversaries the market is celebrating this month.

I put celebrating in quotes because the first of those two anniversaries was the top of the Internet bubble in March 2000, 18 years ago. The bursting of that bubble is something many of us would just as soon forget, of course, since the Nasdaq Composite index
COMP, -2.43%
subsequently lost nearly 80% of its value.

Top 5 Value Stocks To Buy For 2018: Vuzix Corporation(VUZI)

Advisors’ Opinion:

  • [By William Patalon III]

    Vuzix Corp. (Nasdaq: VUZI) – the “augmented reality” company whose shares more than doubled following our September 2015 recommendation – said that its new “smart glasses” were just honored with a “Wearable Device of the Year” award.

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By James E. Brumley]

    While the economy’s natural — and recurring — cycles favor different kinds of stocks at different times, not every great trend is necessarily a cyclical one. Sometimes, a trend is rooted in a technological development that changes cultural norms. The advent of the smartphone, for example, has made constant connectivity to the world around part of how we live our daily lives.

    These mega-trends present tremendous opportunities for investors too, provided they’re savvy enough to see them coming and play them the right way.

    One such mega-trend newly underway right now is the proliferation of wearables… devices that meld clothing (often a wrist-worn device) and technology to perform a function that couldn’t be performed otherwise. Much of the same technology that made the smartphone possible are now ushering in wearables.

    It’s not been a smooth beginning. however.

    While the buzz was strong and expectations reached a peak two years ago when Fitbit Inc (NYSE:FIT) was all the rage and in the wake of its IPO, the company’s growth wasn’t to be sustained. The company is struggling to muster any growth now, and FIT shares have fallen to a tenth of their value seen in late-2015, when the euphoria was strongest.

    Fitbit’s slowdown has been mirrored by other companies in the space. The wearables market only grew 3.1% in Q3 of 2016.

    On the flipside, while the debacle of Fitbit — the wearable industry’s iconic company — has been a painful, it’s also been a learning experience. And, it’s not as if the slowdown is unfurling without the wearables market never reaching a respectable size. International Data Corporation estimates were 23 million ‘wearables’ delivered in the third quarter of last year alone.

    Moreover, the fizzling of the market hasn’t turned into a reason to swear off wearables as an investment opportunity… quite the opposite, actually. It’s just now become considerably clearer what consumers want an

Top 5 Value Stocks To Buy For 2018: Tronox Limited(TROX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Tronox Ltd (NYSE: TROX) were down 23 percent to $19.55. The FTC has challenged Tronox acquisition of Cristal’s titanium dioxide business. Tronox disclosed that it will fight FTC lawsuit seeking to block proposed acquisition of Saudi-owned Cristal.

  • [By Lisa Levin]

    Tronox Ltd (NYSE: TROX) shares shot up 34 percent to $19.30. Tronox announced plans to acquire Cristal's TiO(2) business and also agreed to sell Alkali Business. Tronox posted a Q4 loss of $0.14 per share on revenue of $548 million.

Top 5 Value Stocks To Buy For 2018: Sunoco LP(SUN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) and Sunoco LP (NYSE: SUN).

  • [By Douglas A. McIntyre]

    Exxon Mobil Corp. (NYSE: XOM) is the second largest company in America and the world’s largest oil company. Chevron Corp. (NYSE: CVX) is the third largest company in the United States. Valero Corp. (NYSE: VLO) is among the world’s largest refiners. Sunoco L.P. (NYSE: SUN) is one of North America’s largest owners of stations and convenience stores. BP PLC (NYSE: BP) is among the world’s oil behemoths. Shell is the U.S. branch of oil giant Royal Dutch Shell PLC (NYSE: RDS-A).

  • [By ]

    That’s the case for Sunoco (NYSE: SUN). After posting a net loss of $0.09 per share in 2017, the gas station owner is expected to swing to a hefty profit of $2.35 per share in 2018. But of the 14 analysts who follow the company, earnings estimates range as low as $1.22 and as high as $3.35 — so there is a high degree of uncertainty.

Top 5 Value Stocks To Buy For 2018: Genfit SA (GNFTF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In a recent article, we discussed what makes Genfits (OTCPK:GNFTF) Elafibranor one of the most promising candidates in the NASH treatment development space. Given the unmet need (no approved therapies), Elafibranors mechanism of action and the potential it has shown in clinical stages, we see a strong chance of approval if the pivotal Phase 3 study succeeds. In this article, we will briefly discuss the chances of Elafibranors success in clinical stages and Genfits valuation based on the potential of its lead product candidate. We will briefly also discuss the risks to the investment thesis.

Top 5 Value Stocks To Buy For 2018: Theravance Biopharma, Inc.(TBPH)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    The exact date Theravance Biopharma Inc. (TBPH) intends to release a phase 3 update on COPD treatment Revefenacin isnt known. The company simply said in a prior communication with the market it would be sharing an interim look at the trials progress sometime in early Q4.